Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus

被引:0
作者
Gennaro Giustino
Lisandro D. Colantonio
Todd M. Brown
April P. Carson
Yuling Dai
Michael E. Farkouh
Keri L. Monda
Paul Muntner
Robert S. Rosenson
机构
[1] Icahn School of Medicine at Mount Sinai,Department of Epidemiology
[2] University of Alabama at Birmingham,Department of Medicine
[3] University of Alabama at Birmingham,Peter Munk Cardiac Centre and the Heart and Stroke Richard Lewar Centre
[4] University of Toronto,The Zena and Michael A. Wiener Cardiovascular Institute, Cardiometabolics Unit
[5] Center for Observational Research,undefined
[6] Amgen Inc.,undefined
[7] Icahn School of Medicine at Mount Sinai,undefined
来源
Cardiovascular Drugs and Therapy | 2018年 / 32卷
关键词
Statins; Diabetes mellitus; Myocardial infarction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:453 / 461
页数:8
相关论文
共 173 条
[1]  
Stone NJ(2014)2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2889-2934
[2]  
Robinson JG(2015)Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association Circulation 132 691-718
[3]  
Lichtenstein AH(2017)Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study Int J Cardiol 246 20-25
[4]  
Bairey Merz CN(2016)Safety and efficacy of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention: from the REPLACE-2, ACUITY and HORIZONS-AMI trials Am J Cardiol 118 6-16
[5]  
Blum CB(1998)Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229-234
[6]  
Eckel RH(2014)Patterns and predictors of intensive statin therapy among patients with diabetes mellitus after acute myocardial infarction Am J Cardiol 113 1267-1272
[7]  
Fox CS(2015)Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease J Am Coll Cardiol 65 270-277
[8]  
Golden SH(2017)Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014 J Am Coll Cardiol 69 2696-2706
[9]  
Anderson C(2006)Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease J Manag Care Pharm 12 546-554
[10]  
Bray GA(2013)Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG) Am Heart J 166 709-715